BAQSIMI vs GVOKE VIALDX
Independent side-by-side comparison.
Rating
70/100
New
Pharmacy pays
~$5930.62 /30
~$5930.62 /30
Type
RX
RX
Active ingredient
GLUCAGON
GLUCAGON
Manufacturer
Dosage forms
Powder
Injectable
Drug class
Antihypoglycemic Agent
Antihypoglycemic Agent
Boxed warning
None
None
Treats
Anaphylaxis, Bradycardia, Hypoglycemia
Anaphylaxis, Bradycardia, Hypoglycemia
Frequently asked questions
Which is cheaper, Baqsimi or Gvoke Vialdx?
Pharmacies pay about the same to acquire either one — roughly $5930.62 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.
What is the difference between Baqsimi and Gvoke Vialdx?
Both Baqsimi and Gvoke Vialdx share the active ingredient Glucagon.
Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.